Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TRNAG1 gene

Known as: TRANSFER RNA GLYCINE 1, TRNAG1, TRG1 
 
National Institutes of Health

Related topics

Related topics

2 relations
GlycineTRG-GCC2-6 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival.
Histopathologic tumor regression grades (TRGs) after neoadjuvant chemotherapy predict survival in different cancers. In bladder… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Surgical resection of primary gastric lesions after neoadjuvant or palliative chemotherapy is performed for curative or… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2012
Highly Cited
2012
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
PURPOSE MicroRNAs (miRNAs) are small, noncoding RNA molecules that can be down- or upregulated in colorectal cancer and have been… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2011
2011
Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer.
PURPOSE To assess the prognostic value of the Mandard tumour regression score (TRG) following pre-operative chemo/radiotherapy in… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2010
2010
Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation.
BACKGROUND AND PURPOSE To explore the utility of tumour regression grading (TRG, the amount of residual tumour cells in relation… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy
BackgroundLocally advanced rectal cancer is frequently treated with neoadjuvant chemoradiotherapy to reduce local recurrence and… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Genomic organization and recombinational unit duplication-driven evolution of ovine and bovine T cell receptor gamma loci
BackgroundIn humans and mice ("γδ low species") less than 5% of the peripheral blood T lymphocytes are gamma/delta T cells… Expand
  • figure 5
  • table 1
  • figure 5
  • table 2
  • figure 10
Is this relevant?
2006
2006
Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
PURPOSE Epidermal growth factor receptor (EGFR) has been associated with radioresistance in solid tumors. Recently a polymorphism… Expand
Is this relevant?
2006
2006
Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
PURPOSE To investigate the effect and feasibility of concurrent radiation and chemotherapy combined with endorectal brachytherapy… Expand
Is this relevant?
2006
2006
Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I–II study
Oxaliplatin (OXA), raltitrexed (RTX), 5-fluorouracil (FU) and folinic acid (FA) have shown activity in metastatic colorectal… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE